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Context: A diminished muscle anabolic response to protein nutrition may underpin age-associated
muscle loss.
Objective: To determine how chronological and biological aging influence myofibrillar protein
synthesis (MyoPS).
Design: Cross-sectional comparison.
Setting: Clinical research facility.
Participants: Tenolder lean [OL: 71.766 years; bodymass index (BMI)#25 kg $m22], 7 older obese (OO:
69.162 years; BMI$30 kg $m22), and 18 young lean (YL) individuals (25.564 years; BMI#25 kg $m22).
Intervention: Skeletal muscle biopsies obtained during a primed-continuous infusion of L-[ring-
13C6]-phenylalanine.
MainOutcomeMeasures:Anthropometrics, insulin resistance, inflammatorymarkers, habitual diet,
physical activity, MyoPS rates, and fiber-type characteristics.
Results: Fat mass, insulin resistance, inflammation, and type II fiber intramyocellular lipid were
greater, and daily step count lower, in OO compared with YL and OL. Postprandial MyoPS rates rose
above postabsorptive values by ;81% in YL (P, 0.001), ;38% in OL (P = 0.002, not different from
YL), and;9% in OO (P = 0.11). Delta change in postprandial MyoPS from postabsorptive values was
greater in YL compared with OL (P = 0.032) and OO (P, 0.001). Absolute postprandial MyoPS rates
and delta postprandial MyoPS change were associated with step count (r2 = 0.33; P = 0.015) and leg
fat mass (r2 = 0.4; P = 0.006), respectively, in older individuals. Paradoxically, lean mass was similar
between groups, and muscle fiber area was greater in OO vs OL (P = 0.002).
Conclusion:Age-relatedmuscle anabolic resistance is exacerbated in obese inactive individuals, with
no apparent detriment to muscle mass. (J Clin Endocrinol Metab 102: 3535–3545, 2017)
A ge-related muscle loss [sarcopenia (1)] impairsphysical function, increases the risk of falls/fractures
and metabolic disease, and is associated with mortality
(2–5). As the number of older individuals globally rises
dramatically over the next 30 years, so too will the
prevalence of sarcopenia, placing a considerable strain on
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health care resources (6, 7). Recent studies demonstrate
that a diminished muscle myofibrillar protein synthesis
(MyoPS) response to protein/amino acid provision in
the old may underlie the progression of sarcopenia
(8, 9). This age-related muscle anabolic resistance is
apparent in response to low- to moderate-dose protein
intake (10, 11), common in the diet of older individuals
(12). The underlying mechanisms of age-related muscle
anabolic resistance are unclear, but are essential to
understand to develop interventions to maintain/
improve musculoskeletal health.
Although the etiology of sarcopenia is undoubtedly
multifactorial, there is contention as to the role of
chronological and biological aging in this process (13). It is
well accepted that chronological aging is accompanied by
declining physical activity levels, interspersed by pro-
tracted disuse events (i.e., during illness/hospitalization)
(14, 15). This is noteworthy, as it has been demonstrated
that bed rest (16), limb immobilization (17), and reduced
daily activity (18) induce muscle anabolic resistance and
atrophy in older individuals, whereas acute treadmill
walking restores postprandial muscle anabolic respon-
siveness (19). Thus, although physical activity represents an
important locus of control in age-related MyoPS, very few
studies have assessed physical activity levels in conjunction
with MyoPS in older individuals and, as such, any positive
association between the two is lacking.
Sarcopenia is often accompanied by a concomitant
increase in adiposity and intramuscular fat infiltration
(myosteatosis) (20, 21), the confluence of which has been
associated with a more rapid progression toward frailty
and metabolic disease (22, 23). Indeed, a blunted MyoPS
response to amino acid administration was recently
demonstrated in obese vs normal-weight older males
(24). Furthermore, high-fat diets, lipid administration,
obesity, and ectopic fat deposition induce whole-body
and muscle anabolic resistance in rodents and humans
(25–29), although postprandial MyoPS rates are not
impaired in nonobese patients with type 2 diabetes (30,
31). Collectively, these data suggest that obesity, but not
insulin resistance per se, may impair MyoPS, potentially
through compromisedmuscle quality or elevated levels of
adipose-derived inflammatory cytokines (32). Currently,
the role of myosteatosis, insulin resistance, and in-
flammation on age-related muscle anabolic resistance is
unclear and warrants further investigation.
Therefore, the aim of the current study was to com-
prehensively assess the physical activity, whole-body/
muscle metabolic health, and inflammatory charac-
teristics of (1) young lean (YL), (2) older lean (OL), and
(3) older obese (OO) individuals to establish whether,
and to what extent, these parameters were associated
with MyoPS in the postabsorptive state and in response
to moderate-dose protein provision. We hypothesized that
postprandial MyoPS rates would be impaired in OL, but
more so inOO individuals compared with YL individuals
and would therefore be closely associated with levels of
physical activity, adiposity, and inflammatory markers.
Materials and Methods
Participants
Ten OL and 10 OO individuals were recruited for com-
parison against 18 YL individuals (Table 1). Participants
completed a general health questionnaire and were excluded
from participating if they had type 2 diabetes, uncontrolled
hypertension, neuromuscular/cardiovascular/metabolic dis-
ease, or if they were smokers, losing weight, or taking non-
steroidal anti-inflammatory drugs. Participants were informed
of the purpose and methodology of the study prior to providing
written consent. Ethical approval was obtained through the
NHS Black Country Research Ethics Committee (13/WM/
0429). The study conformed to standards set by the Declara-
tion of Helsinki (seventh edition). Three OO participants were
omitted from the study due to the detection of one or more
exclusion criteria during preliminary assessments (n = 2) and
noncollection of muscle biopsy tissue (n = 1).
Experimental design
Following an initial screening visit, participants reported
to the National Institute for Health Research/Wellcome Trust
Clinical Research Facility (CRF) of the Queen Elizabeth Hospital,
Birmingham, United Kingdom, over two visits for preliminary
assessments of dietary intake, physical activity, body composi-
tion, and whole-body indices of metabolic health/inflammation.
During a third visit, participants underwent a stable amino acid
isotope tracer infusion with serial muscle biopsies and blood
samples to determine MyoPS rates in the basal postabsorptive
state and in response to a moderate-dose milk protein isolate
drink (hereafter termed postprandial), intracellular signaling, and
muscle fiber/intramyocellular lipid (IMCL) properties.
Preliminary assessments
Body composition
Participants reported to the CRF at ;0800 h, following a
10-hour overnight fast. Following assessment of height and
weight, dual energy x-ray absorptiometry scanning (GE iDXA;
GEHealthcare, Chicago, IL) was used to determine whole-body
and regional fat mass, lean mass, and visceral adipose tissue
(VAT). VAT was obtained by identifying the android/gynoid
region and the horizontal plane by the area between the
pelvis and the rib cage, with its vertical limits being the inner
abdominal muscle wall. VAT is computed by subtracting
subcutaneous fat from the total android fat mass in the
android region. Obesity was defined by body mass index
(BMI) $30 kg $ m22.
Resting metabolic rate
Participants rested in a supine position for 30 minutes while
expired gases were collected via a ventilated plastic hood and
analyzed for O2 and CO2 concentrations using a Moxus met-
abolic cart (AEI Technologies, Naperville, IL), equipped with
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electrochemical gas analyzers (AME-TEK model S-3A/1 and
CD-3A). Breath-by-breath measurements were analyzed for
volume of oxygen (VO2) and volume of CO2 (VCO2) and values
averaged over 30-second periods using Moxus software
(version 2.8.02). Participants were instructed to lie as still as
possible, breathe normally, not speak, and stay awake. Resting
metabolic rate (RMR) was predicted using the Weir equation
[RMR= (3.943VO2) + (1.113VCO2)] based upon a 5-minute
measurement period during which VO2 measurements showed
the lowest coefficient of variation.
Fasting plasma blood glucose and hemoglobin A1C
Following RMR assessment, a 10-mL venous blood sample
was obtained to measure fasting plasma glucose and hemo-
globin A1C concentrations. Participants were excluded from
study participation if fasting plasma glucose and hemoglobin
A1C values exceeded 7 mmol/L and 48 mmol/mol, respectively,
indicating high risk or presence of type 2 diabetes.
Physical activity/intensity levels
Participants were fitted with a wrist-worn accelerometer
with a triaxial sensor (GENEActiv; Activinsights, Huntingdon,
United Kingdom) for 4 consecutive days, including at least
1 weekend day. Accelerometers were initialized to sample data
at a 10-Hz frequency. Data were converted into 60-second
epochs and analyzed using the GENEActiv software (version
2.2; Activinsights). Activities were split into four categories
based on metabolic equivalent (MET) values: (1) sedentary
activity (,1.5 METs), (2) light activity (1.5 to 3.99 METs),
(3) moderate activity (4.0 to 6.99 METs), and (4) vigorous
activity (.7 METs) (33). Participants also recorded their daily
step count over 4 consecutive days using a hip-worn pedometer
(Vital Steps; Omron Healthcare Co. Ltd., Milton Keynes,
United Kingdom).
Dietary intake
Habitual dietary intake was assessed over a 4-day period.
Participants were given a food diary and digital balance scales to
record andweigh out their dietary and fluid intake. Food diaries
were analyzed using Dietplan software (Dietplan 7; Forestfield
Software Ltd, West Sussex, United Kingdom).
Experimental trial
The evening prior to the experimental trial, participants
consumed a standardized evening meal (787 kcal) composed of
;19% protein, ;46% carbohydrate, and ;35% fat. After an
;10- to 12-hour overnight fast and having refrained from any
strenuous activity for 48 hours previously, participants reported
to the CRF at 0730 hours by car or public transport. Upon
arrival, a 21-gauge cannulawas inserted into an antecubital vein
of both forearms for serial blood sampling throughout the day
and administration of a primed continuous infusion of L-[ring-
13C6] phenylalanine (prime dose 2 mmol $ kg
21; continuous
infusion 0.05 mmol $ kg212$ min21; Cambridge Isotope
Laboratories, Andover, MA), initiated after obtainment of a
baseline blood sample. Arterialized blood samples were drawn
at2180,295,235, and25minutes prior to and 20, 40, 60, 90,
120, 180, and 240 minutes after a milk protein beverage from a
heated forearm vein (60°C). Blood samples were collected in
serum separator and EDTA-treated vacutainers (BD Bio-
sciences, Oxford, United Kingdom) and centrifuged at
3000 rpm for 10 minutes at 4°C, with plasma and serum ali-
quots stored at280°C. After 150 minutes of infusion, a muscle
biopsy was obtained from quadriceps vastus lateralis of a
Table 1. Anthropometric, Body Composition, and Metabolic Health Data
YL OL OO
Participants (male/female) 10/8 4/6 4/3
Age (y) 25.5 6 3.7 71.7 6 6.2a 69.1 6 2.6a
Body mass (kg) 70.1 6 12.9 64.5 6 10.9 91.6 6 15a,b
BMI (kg $ m22) 23.3 6 2.4 22.7 6 2.5 32.9 6 4a,b
Fat mass (% of body mass) 24.3 6 6.5 28.3 6 7.1 41 6 2a,b
Fat mass (kg) 16.8 6 5.6 17.7 6 4.4 36.7 6 6.4a,b
Leg fat mass (kg) 6.6 6 2.5 5.8 6 1.3 9.9 6 2.1a,b
Visceral adipose tissue (kg) 0.23 6 0.15 0.58 6 0.48 2.76 6 1.44a,b
Lean mass (kg) 49.7 6 10 43 6 9.6 50.3 6 8.8
Lean mass (% of body mass) 71 6 6.3 66.5 6 7.3 54.8 6 2.1a,b
Leg lean mass (kg) 16.7 6 3.4 14 6 3.6 17.1 6 3.4
Leg lean mass (% of body mass) 23.8 6 2.14 21.6 6 2.6c 18.6 6 1.3a,d
HOMA-IR 2.28 6 0.91 2.16 6 0.98 6.10 6 3.02a,d
Fasting plasma glucose (mmol/L) 5.3 6 0.5 5.9 6 0.5a 6.5 6 0.3a
Fasting serum insulin (mIU/mL) 9.7 6 3.7 8.2 6 3.5 21.1 6 10.6a,b
Plasma IL-6 (pg/mL) 0.43 6 0.29 1.1 6 0.51a 1.49 6 0.71a
Plasma CRP (mg/L) 0.37 6 0.14 0.92 6 0.34 2.34 6 0.98a,b
Plasma HbA1C (mmol/mol) — 37.3 6 3.9 38.3 6 3.4
RMR (kcal) 1681 6 296 1276 6 353c 1515 6 449
Data presented as mean 6 standard deviation.
Abbreviation: HOMA-IR, homeostasis model assessment of insulin resistance.
aP , 0.01, significantly different from YL.
bP , 0.01, significantly different from OL.
cP , 0.05, significantly different from YL.
dP , 0.05, significantly different from OL.
doi: 10.1210/jc.2017-00869 https://academic.oup.com/jcem 3537
randomly selected leg under local anesthesia (1% lidocaine)
using the Bergstro¨m technique. Biopsy samples were freed from
visible blood, adipose, and connective tissue using ice-cold
saline, snap-frozen in liquid nitrogen, and stored at 280°C
for analysis of MyoPS and intramuscular signaling. A separate
piece of muscle tissue (;20 mg) was mounted in O.C.T.
compound (VWR Chemicals, Leuven, Belgium) and frozen in
2-methylbutane (Sigma-Aldrich, St. Louis, MO) before being
stored at 280°C for immunohistochemical analyses. Immedi-
ately after biopsy obtainment, participants consumed a 15-g
dose of milk protein isolate (MyProtein, Cheshire, United
Kingdom) dissolved in 300mLwater. The amino acid content of
the milk protein isolate was (as percentage content): alanine,
3.0; arginine, 3.7; asparagine, 7.4; cysteine, 0.9; glutamine, 9.1;
glycine, 1.7; histidine, 2.3; isoleucine, 5.6; leucine, 9.8; lysine,
8.7; methionine, 2.6; phenylalanine, 4.7; proline, 9.9; serine,
5.3; threonine, 3.8; tryptophan, 1.7; tyrosine, 4.6; and valine,
6.0, providing 13.6 g amino acids in total. A small amount of
L-[ring-13C6] phenylalanine tracer was added to the drink to
minimize changes in 13C6 phenylalanine enrichment (28.2mg to
enrich to 4%) (34). Approximately 240 minutes after drink
consumption, a second biopsy was obtained;3 cm proximal to
the first biopsy and indicated the end of the experimental trial.
Participants were fed a meal of their choice and monitored for
30 minutes before leaving the CRF.
Blood analyses
Blood analyte and hormone concentrations
Plasma glucose was analyzed by enzymatic colorimetric
assay (Glucose Oxidase kit; Instrumentation Laboratory,
Warrington, United Kingdom) using an ILAB 650 Clinical
Chemistry Analyzer (Instrumentation Laboratory). Plasma
HbA1C concentration was analyzed via a Tosoh G8 HPLC
semiautomated analyzer (Tosoh Bioscience, King of Prussia,
PA). Serum interleukin-6 (IL-6), C-reactive protein (CRP),
and insulin concentrations were measured using commercially
available enzyme-linked immunosorbent assay kits (IL-6:
R&D Systems Europe, Abingdon, United Kingdom; CRP:
RayBiotech, Norcross, GA; insulin: IBL International, Ham-
burg, Germany).
Plasma amino acid enrichment and concentrations
Plasma 13C6 phenylalanine enrichment was determined by
gas chromatography mass spectrometry alongside leucine and
phenylalanine concentrations, as previously described (35).
Muscle tissue analyses
Myofibrillar protein enrichment and
intramuscular signaling
Approximately 30 to 40 mg of muscle tissue was minced in
10 mL/mg of homogenization buffer (50 mM Tris-HCL, 1 mM
EDTA, 1 mM EGTA, 10 mM b-glycerophosphate, 50 mM
sodium fluoride, and one protease inhibitor tablet per 10 mL of
homogenization buffer, pH 7.5) on ice using small scissors and
a Teflon pestle before being shaken for 10 minutes at 1500 rpm
at room temperature and centrifuged at 11,000 rpm at 4°C
for 5 minutes. The supernatant containing the sarcoplasmic
proteins was transferred to a 2-mL eppendorf for western
blotting according to our previous work (35). The remaining
myofibrillar pellet was processed and analyzed for 13C6 en-
richment according to our previous work (35). Primary anti-
bodies used for western blotting were: phospho p70S6K1
Thr389 (#9205), total p70S6K1 (#9202), phospho–eukaryotic
initiation factor 4E binding protein (4E-BP1) Thr37/46 (#9459),
total 4E-BP1 (#9452), phospho–eukaryotic elongation factor 2
(p-eEF2) Thr56 (#2331), total eEF2 (#2332), phospho–protein
kinase B (Akt) Ser473 (#3787), and total Akt (#9272) from Cell
Signaling Technology (New England Biolabs Ltd, Hitchin,
United Kingdom).
Fiber-type IMCL
Muscle cross sections (5 mm) were fixed for 1 hour in 3.7%
formaldehyde, washed briefly in double-distilled H2O, per-
meabilized for 5 minutes in 0.5% Triton X-100, and washed
three times for 5minutes in 13 phosphate-buffered saline (PBS).
Cross sections were then incubated for 2 hours in myosin heavy
chain type I antibody [A4.840, DHSB; developed by Dr. H. M.
Blau (Baxter Lab for Stem Cell Biology, Stanford University,
CA), IA (1:25 diluted in 5% normal goat serum and PBS)],
washed three times for 5 minutes in PBS, and subsequently
incubated for 30 minutes in goat anti-mouse IgM 594
[#A21044; Thermo Fisher Scientific, Leicestershire, United
Kingdom (1:50 diluted in PBS)]. After three 5-minute washes in
PBS, sections were incubated for 30 minutes in wheat germ
agglutinin stock solution [W11263; Alexa Fluor 350; Thermo
Fisher Scientific (1 mg/mL, diluted 1:100 in PBS)] and washed
two times for 3 minutes in PBS. Finally, sections were incubated
for 20 minutes in bodipy-493/503 stock solution [D3922;
Thermo Fisher Scientific (1 mg/mL, diluted 1:50 in PBS)] and
washed three times for 3 minutes in PBS. Coverslips were ap-
plied using amounting solution containing glycerol andmowiol
4-88 solution (Sigma-Aldrich) in 0.2 M Tris buffer (pH 8.5)
with 0.1% 1,4-diazabicyclo-[2,2,2]-octane (DABCO) antifade
medium. Images were taken with an Eclipse E600 (Nikon,
Badhoevedorp, the Netherlands) and a 403 zoom and analyzed
using Pro Suite version 5.1.2.59.
Calculations
The precursor-product method was used to calculateMyoPS









where D Eb is the algebraic difference in bound
13C6 phenyl-
alanine between biopsy samples, Ep is the precursor enrichment
(mean plasma 13C6 phenylalanine enrichment from arterialized
blood), and t is the time between biopsy samples (in minutes).
Preinfusion plasma 13C6 phenylalanine enrichment was used
as a proxy for basal muscle protein enrichment, as previously
validated in young and older individuals (34, 36).
Statistics
Data analysis was performed using SPSS version 22 (IBM,
Chicago, IL) and Prism 6 (GraphPad Software, La Jolla, CA).
A Shapiro-Wilks test was used to test the normality of the
data. Subsequently, nonnormally distributed variables were
logarithmically transformed. MyoPS rates and intracellular
signaling were analyzed using a two-way, repeated-measures
analysis of variance (ANOVA) with one within (two
levels—postabsorptive and postprandial) and one between
factor (three levels; group). Insulin, plasma amino acid, and
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13C6 phenylalanine enrichment were analyzed using a one-
way, repeated-measures ANOVA (time 3 group). Linear re-
gression was performed on 13C6 phenylalanine enrichments
to assess the existence of any deviation in enrichment. All
other data points were analyzed using a one-way ANOVA.
Tukey honest significant difference post hoc analysis was
performed whenever a noteworthy F ratio was found to
isolate specific differences. Correlational analysis was per-
formed using a two-tailed Pearson correlation coefficient test
or Spearman test (for nonnormally distributed data). Signifi-
cance for all analyses was set at P , 0.05. All values are
presented as means 6 standard deviation or standard error of
the mean.
Results
Anthropometric andmetabolic health characteristics
Body mass, BMI, fat mass, and VATwere significantly
greater in OO compared with OL and YL (P , 0.05),
with no differences between YL andOL. The whole-body
absolute lean mass and lower limb absolute lean mass
were not significantly different between groups. Whole-
body lean mass, expressed relative to total body mass,
was significantly lower in OO compared with YL andOL
(P, 0.001 and P = 0.001, respectively). Relative leg lean
mass was lower in OO and OL compared with YL (P ,
0.001 and P = 0.038, respectively) and lower in OO
compared with OL (P = 0.023). Plasma IL-6, CRP,
glucose, serum insulin, and homeostasis model assess-
ment of insulin resistance were significantly greater in
OO compared with OL and YL (P , 0.01). RMR was
significantly lower in OL compared with YL only (P =
0.015). Anthropometric and metabolic health charac-
teristics are presented in Table 1.
Physical activity and dietary characteristics
Average daily step countwas significantly lower inOO
compared with OL and YL (P , 0.01). Relative and
absolute time spent in light intensity activity was sig-
nificantly greater in OL compared with YL (P = 0.003),
but not different from OO. Dietary protein intake was
significantly lower in OO compared with YL (P = 0.009),
but not different from OL. Physical activity and dietary
characteristics are detailed in Table 2.
Muscle fiber characteristics and lipid content
Type I and II muscle fiber cross-sectional area (CSA)
was greater in YL compared with OO and OL (P ,
0.001 for both) and significantly greater in OO com-
pared with OL (P = 0.004 and P , 0.001, respectively).
Type I fiber lipid droplet number was significantly
greater in YL compared with OL (P, 0.001) and OO (P
= 0.021) and was greater in OL compared with OO (P,
0.001). Type II fiber lipid droplet number was signifi-
cantly greater in YL and OO compared with OL (P ,
0.001 for both) with no difference between YL and OO.
Type I lipid droplet area (normalized to fiber CSA) was
lower in OL compared with YL (P = 0.014) but not OO,
whereas type II lipid droplet area was significantly
greater in OO compared with YL (P , 0.001) and OL
(P = 0.042). Muscle fiber and IMCL characteristics
are presented in Table 3.
Plasma amino acid and insulin concentrations
Plasma leucine and phenylalanine concentrations in-
creased above basal-fasted values after ingestion of 15 g
of milk protein isolate [P , 0.001; Fig. 1(a) and 1(b)],
peaking between 20 and 40 minutes post-ingestion and
Table 2. Activity and Diet Characteristics
YL OL OO
Daily step count 11,870 6 3905 11,102 6 3271 5399 6 2079a,b
Sedentary activity (%) 70.8 6 6.6 65.5 6 13.8 74.9 6 7.4
Light activity (%) 10.2 6 2.1 15 6 5.2c 11 6 2.4
Moderate activity (%) 16.8 6 5.2 18.4 6 9.7 13.9 6 5.9
Vigorous activity (%) 2.3 6 2.8 0.8 6 1.5 0.2 6 0.1
Sedentary activity (min) 643 6 56 594 6 115 684 6 104
Light activity (min) 93 6 19 140 6 50c 101 6 24
Moderate activity (min) 153 6 53 169 6 89 126 6 48
Vigorous activity (min) 21 6 26 7 6 14 2 6 1
Daily energy intake (kcal) 2162 6 473 2091 6 451 2412 6 628
Daily protein (g $ kg21) 1.51 6 0.46 1.36 6 0.37 0.95 6 0.20a
Daily CHO (g $ kg21) 3.20 6 1.22 3.38 6 0.91 2.65 6 1.25
Daily fat (g $ kg21) 1.17 6 0.33 1.29 6 0.46 1.07 6 0.40
Daily alcohol (g $ kg21) 0.22 6 0.22 0.22 6 0.25 0.33 6 0.25
Daily fiber (g $ kg21) 0.30 6 0.14 0.34 6 0.10 0.24 6 0.12
Values presented as mean 6 standard deviation.
aP , 0.01, significantly different from YL.
bP , 0.01, significantly different from OL.
cP , 0.05, significantly different from YL.
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returning to basal-fasted values by 180 and 90 minutes
postingestion, respectively, with no difference between
groups. Basal-fasted serum insulin concentration was
significantly elevated in OO compared with YL and OL
(P , 0.001). Serum insulin levels increased above basal-
fasted values at 20 minutes post-ingestion (P , 0.01 for
all), returning to basal-fasted values by 60 minutes post-
ingestion [Fig. 1(c)]. Absolute serum insulin values at
20 and 40 minutes after protein ingestion were greater in
OO compared with YL (P = 0.004 and 0.016, respectively)
and OL (P = 0.001 and 0.007, respectively), with no dif-
ference between YL and OL. Plasma 13C6 phenylalanine
enrichment increased above basal (2180 minutes) values
60 minutes after the initiation of the stable isotope tracer
infusion (P, 0.001) and remained stable for the entire trial
duration [Fig. 1(d)]. The slopes of the plasma 13C6
phenylalanine enrichment were not significantly different
from zero, indicating the presence of an isotopic steady
state (P = 0.3).
MyoPS and intramuscular signaling
Postabsorptive MyoPS rates did not differ between
groups. Following ingestion of 15 g of milk protein
isolate, MyoPS rates increased by ;81% in YL (P ,
0.001) and ;38% in OL (P = 0.002), respectively, with
no notable increase found in OO (P = 0.11). Postprandial
MyoPS rates were significantly greater in YL compared
with OO (P = 0.02), but were not different between YL
and OL (P = 0.21) or between OL and OO [P = 0.11;
Fig. 2(a)]. The net postprandial MyoPS response,
expressed as the delta change from postabsorptive rates,
was significantly greater in YL compared with OL (P =
0.032) and OO (P , 0.001), with no considerable dif-
ference found between OL and OO [P = 0.173; Fig. 2(b)].
Phosphorylation of p-70S6KThr389, AktSer473, eEF2Thr56,
and 4E-BP1Thr37/46 was not significantly different from
basal-fasted values at 240 minutes after protein con-
sumption and was not different between groups at any
time point (Supplemental Figs. 1 and 2).
Correlations
Absolute postprandial MyoPS rates showed a ten-
dency to correlate negatively with leg fat mass [r2 = 0.20;
P = 0.07; Fig. 3(a)] and correlated positively with average
daily step count in OL and OO combined [r2 = 0.33; P =
0.015; Fig. 3(b)]. The net postprandial MyoPS response
(i.e., delta change from postabsorptive values) correlated
negatively with leg fat mass [r2 = 0.4; P = 0.006; Fig. 3(c)]
and positively with average daily step count for OL and
OO combined [r2 = 0.26; P = 0.036; Fig. 3(d)]. HOMA-
IR correlated positively with type I fiber lipid droplet
number (r2 = 0.41; P = 0.018), type I fiber lipid droplet
area (r2 = 0.47; P = 0.009), leg fat mass (r2 = 0.4; P =
0.007), and average daily step count (r2 = 0.26; P = 0.036)
for OL and OO combined. Although not significant,
there was a trend for a negative correlation between the
net postprandial MyoPS response and serum CRP in
older individuals (r2 = 0.23; P = 0.050).
Discussion
Age-related impairment in the muscle protein synthetic
response to protein-based nutrition is thought to be the
primary metabolic defect underpinning the progression
of sarcopenia (10). Towhat extent this age-relatedmuscle
anabolic resistance is a consequence of chronological
and/or aspects of biological aging is unknown. The
present data demonstrate that MyoPS rates are increased
above postabsorptive values following moderate-dose
milk protein ingestion in YL and OL, but not OO in-
dividuals. Although there was no difference in absolute
postprandial MyoPS rates between YL and OL, the net
Table 3. Muscle Fiber and IMCL Characteristics
YL OL OO
Type I fiber (%) 48 6 16 49 6 18 36 6 15
Type II fiber (%) 52 6 16 51 6 18 65 6 16
Type I area (mm2) 4031 6 1978 3009 6 1251a 3421 6 1528a,b
Type I lipid droplet number 616 6 458 412 6 298a 533 6 505b,c
Type I lipid droplet area (mm2) 287 6 238 175 6 159a 244 6 267b,c
Type I lipid droplet area (% fiber area) 0.077 6 0.06 0.064 6 0.063a 0.069 6 0.065
Type II area (mm2) 4009 6 1733 2170 6 1243a 3390 6 1199a,b
Type II lipid droplet number 377 6 399 242 6 312a 415 6 407b
Type II lipid droplet area (mm2) 133 6 157 76 6 99a 201 6 207a,b
Type II lipid droplet area (% fiber area) 0.031 6 0.028 0.032 6 0.034 0.058 6 0.054a,b
Data presented as mean 6 standard deviation.
aP , 0.01, significantly different from YL.
bP , 0.01, significantly different from OL.
cP , 0.05, significantly different from YL.
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postprandial increase in MyoPS rates (delta change from
postabsorptive rates) was greater in YL compared with
both OL and OO. Postprandial MyoPS rates (absolute
and delta change from postabsorptive) were associated
with leg fat mass and average daily step count in older
individuals. Collectively, these data demonstrate that
muscle anabolic resistance to moderate-dose protein in-
gestion is apparent in healthy old age, but is exacerbated
in obese individuals with low physical activity.
In the current study, we provided participants with an
oral 15-g bolus of milk protein isolate (;0.3, 0.35, and
0.3 g $ kg21 $ leanmass21 forYL,OLandOO, respectively),
basedonevidence that age-relatedmuscle anabolic resistance
may be most apparent with low-to-moderate protein doses
typically consumed in the diet (10, 12). This feeding strategy
produced postprandial MyoPS responses that were ;81%
and 38% greater than postabsorptive values in YL and OL,
respectively. Although not statistically different, absolute
postprandial MyoPS rates were 13% lower in OL vs YL.
Furthermore, we observed that the increase inMyoPS above
postprandial values was significantly lower inOL vsYL.We
acknowledge that the differences in net postprandialMyoPS
response between OL and YL we observe in this study may
differwith high-dose protein intake ($30 g) or in the context
of a mixed-macronutrient meal. In line with our findings,
others have reported that ingestion of 20 g of casein protein
increases muscle protein synthesis by ;75% and 21% in
healthy lean young and older males, respectively, with ab-
solute postprandial protein synthesis rates being ;16%
lower in old vs young (37). Additionally, our observations
reveal the inability of OO to increase postprandial MyoPS
above postabsorptive values. Absolute postprandial and net
change in postprandial MyoPS rates were not statistically
lower in OO vs OL, likely due to the relatively small sample
size. However, Murton et al. (24) recently demonstrated an
impaired postprandial MyoPS in obese vs normal-weight
older males. Collectively, our findings provide evidence of
age-related muscle anabolic resistance to moderate-dose
protein ingestion. Furthermore, the associations between
absolute and net postprandial MyoPS responses and leg fat
mass/step count suggest that age-related muscle anabolic
resistance is exacerbated in obese inactive older individuals.
Age-related muscle loss is commonly accompanied
by a concomitant increase in whole-body adiposity and
Figure 1. (a) Plasma leucine concentration, (b) phenylalanine concentration, (c) serum insulin concentration, and (d) plasma 13C6 phenylalanine
enrichment in experimental trials. At t = 0, a 15-g bolus of milk protein isolate was consumed. Values are means 6 standard error of the mean.
Significance was set at P , 0.05. *Significantly greater than fasting values (2180 min); †significantly greater in OO compared with other groups.
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ectopic fat deposition within skeletal muscle (20, 21),
which has been associated with accelerated sarcopenia
progression and metabolic disease risk (23). It has been
postulated that obesity-induced blunting of postprandial
MyoPS might be due to IMCL accumulation (24) or
adipose tissue–derived inflammatory cytokines (adipo-
kines) (38). Alongside the negative association between
the net postprandialMyoPS response and leg fat mass, we
observed a trend for a similar negative association with
fasting serum CRP, but were unable to demonstrate any
association with fiber-specific IMCL content, despite
twofold higher type II fiber IMCL in OO compared with
OL and YL. This was somewhat surprising given pre-
vious reports of associations between IMCL and muscle
anabolic resistance in old rodents (28). In our hands, type I
fiber IMCL content was equivalent between YL and
OO. However, type I fiber IMCL content was negatively
associatedwith insulin sensitivity forOL andOO, but not
YL, reinforcing the notion that the capacity for IMCL
oxidation would likely have been greater in YL (39).
Thus, although we did not observe any association of
fiber-type IMCL content with the postprandial change in
MyoPS, the subcellular location of IMCL and/or specific
class of lipid intermediates (i.e., ceramides and diac-
ylglycerol) may associate more closely with age-related
muscle anabolic resistance.
Despite the near-completely diminished postprandial
MyoPS response in OO, there was no considerable dif-
ference in whole-body or regional lean mass compared
with OL and YL. In fact, muscle fiber CSA was preserved
to a greater extent in OO than OL, although still reduced
compared with YL. Furthermore, the lower RMR in OL
vs YL and OO may be explained by marginally lower
whole-body lean mass. In line with our findings, others
have reported greater lean mass in obese vs normal-
weight older and younger individuals (24, 40). These
data refute the mechanistic role of muscle anabolic re-
sistance in sarcopenia and support the existence of an
age-associated obesity paradox, by which obesity might
protect against sarcopenia (41). Collectively, these data
beg the question, when, if at all, does obesity-induced
muscle anabolic resistance manifest in an accelerated loss
of skeletal muscle in older individuals? We postulate that
the extra work necessary during locomotion and daily
living in OO might offer a degree of protection against
sarcopenia up to a point, beyond which the decline in
muscle mass may be precipitous. Progression toward this
brink may, therefore, be influenced by muscle quality
(i.e., inter- and perhaps intramuscular adiposity) rather
than quantity. Furthermore, the greater insulin resistance
in OO compared with OL could imply that the quality of
muscle tissue retained in old age, and not necessarily the
quantity, may play a more relevant role in whole-body
metabolic health.
Physical activity is an important locus of control in the
regulation of age-related muscle protein turnover. In this
study, we demonstrate that YL andOL took;122% and
106% more daily steps compared with OO, respectively.
Interestingly, postprandial MyoPS (absolute and net in-
crease above postabsorptive values) correlated signifi-
cantly with average daily step count in older individuals,
which aligns with evidence that reduced physical activity
elicits muscle anabolic resistance in older individuals
(18). However, the net postprandialMyoPS response was
still lower in OL compared with YL, despite equivalent
daily physical activity levels, suggesting that increasing
average daily step count in OO, to a level observed in OL
may, at best, only partially restore postprandial MyoPS
responses. Indeed, an acute bout of moderate-intensity
treadmill walking has been reported to enhance post-
prandial muscle protein synthesis rates in older males
Figure 2. (a) Myofibrillar fractional synthesis rate (FSR) in rested
postabsorptive and 4-h postprandial state following ingestion of
15 g of milk protein (dashed line at 0 min), with values presented as
means 6 standard error of the mean. (b) Net postprandial change
in myofibrillar FSR from postabsorptive values, showing the median
(central horizontal line), 25th and 75th percentiles (box), minimum
and maximum values (vertical lines), and mean (cross). Significance
was set at P , 0.05. *Significantly greater than corresponding
postabsorptive values; †significantly greater than OO; ‡significantly
greater than OL.
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(19). The addition of activity-matched OO and OL in-
dividuals would have allowed us to reconcile this im-
portant point, but was beyond the scope of the current
study. We observed no difference between groups in the
relative time spent at different activity intensities or any
association between physical activity intensities and
postprandialMyoPS responses. However, combined time
spent in light plus moderate plus vigorous intensity ac-
tivity revealed a deficit of ;38 and 87 minutes for OO
compared with YL and OL, respectively, which might
explain the lower average daily step count in OO [as-
suming an average of ;100 steps $ min21 and slower
preferred walking speed (42, 43)]. Thus, our findings
suggest a minimum number daily steps (or time spent
active) might offer partial protection against age-related
muscle anabolic resistance.
In conclusion, we have demonstrated that chrono-
logical aging reduces the net postprandial MyoPS re-
sponse to moderate-dose protein ingestion, whereas
obesity and inactivity exacerbate, and are associated
with, this muscle anabolic resistance. Despite the negative
association between leg fat mass and the net postprandial
MyoPS response in older individuals, we were unable to
demonstrate a similar association with fiber-type IMCL
content. Interestingly, despite evidence of exacerbated
muscle anabolic resistance in OO, absolute lean tissue
mass was equivalent and muscle fiber area greater than
OL, which questions the mechanistic role of muscle an-
abolic resistance in sarcopenia. As such, further work is
required to delineate the precise mechanisms through
which obesity and inactivity exacerbate sarcopenia,
particularly in very old individuals. There is also a need to
understand whether the subcellular location of IMCL are
associated with age-related muscle anabolic resistance.
Although we did not directly address sex-based alter-
ations in MyoPS, there was no discernible pattern of
difference between older men and women. Nonetheless,
others have demonstrated sexual dimorphism in muscle
protein synthesis in older individuals (44), and this issue
warrants further clarification. Finally, our data suggest
that physical activity may partially protect against
muscle anabolic resistance in older individuals, al-
though further work is required to determine whether
chronic physical activity interventions can restore
muscle protein anabolism in normal-weight and obese
older individuals.
Figure 3. Correlations between (a) absolute postprandial myofibrillar fractional synthesis rate (FSR) and leg fat mass and (b) average daily step
count in OL and OO combined. Correlations between (c) the delta change in postprandial myofibrillar FSR from postabsorptive values and leg fat
mass and (d) average daily step count in OL and OO combined.
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